Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Expression microarray meta-analysis identifies genes associated with Ras/MAPK and related pathways in progression of muscle-invasive bladder transition cell carcinoma.

Ewald JA, Downs TM, Cetnar JP, Ricke WA.

PLoS One. 2013;8(2):e55414. doi: 10.1371/journal.pone.0055414. Epub 2013 Feb 1.

2.

Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder.

Izawa JI, Slaton JW, Kedar D, Karashima T, Perrotte P, Czerniak B, Grossman HB, Dinney CP.

Oncol Rep. 2001 Jan-Feb;8(1):9-15.

PMID:
11115562
3.

Differences in gene expression between noninvasive and invasive transitional cell carcinoma of the human bladder using complementary deoxyribonucleic acid microarray: preliminary results.

Elsamman E, Fukumori T, Ewis AA, Ali N, Kajimoto K, Shinohara Y, Ishikawa M, Takahashi M, Nishitani MA, Baba Y, Kanayama HO.

Urol Oncol. 2006 Mar-Apr;24(2):109-15.

PMID:
16520272
4.

Implication of RAF and RKIP genes in urinary bladder cancer.

Zaravinos A, Chatziioannou M, Lambrou GI, Boulalas I, Delakas D, Spandidos DA.

Pathol Oncol Res. 2011 Jun;17(2):181-90. doi: 10.1007/s12253-010-9295-1. Epub 2010 Sep 18.

PMID:
20853079
5.

Differential PTEN protein expression profiles in superficial versus invasive bladder cancers.

Koksal IT, Yasar D, Dirice E, Usta MF, Karauzum S, Luleci G, Baykara M, Sanlioglu S.

Urol Int. 2005;75(2):102-6.

PMID:
16123561
6.

Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles.

Modlich O, Prisack HB, Pitschke G, Ramp U, Ackermann R, Bojar H, Vögeli TA, Grimm MO.

Clin Cancer Res. 2004 May 15;10(10):3410-21.

7.
8.

Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.

Shen SS, Smith CL, Hsieh JT, Yu J, Kim IY, Jian W, Sonpavde G, Ayala GE, Younes M, Lerner SP.

Cancer. 2006 Jun 15;106(12):2610-6.

9.

Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors.

Lee JS, Leem SH, Lee SY, Kim SC, Park ES, Kim SB, Kim SK, Kim YJ, Kim WJ, Chu IS.

J Clin Oncol. 2010 Jun 1;28(16):2660-7. doi: 10.1200/JCO.2009.25.0977. Epub 2010 Apr 26.

PMID:
20421545
10.

Gene discovery in bladder cancer progression using cDNA microarrays.

Sanchez-Carbayo M, Socci ND, Lozano JJ, Li W, Charytonowicz E, Belbin TJ, Prystowsky MB, Ortiz AR, Childs G, Cordon-Cardo C.

Am J Pathol. 2003 Aug;163(2):505-16.

11.
12.

Identification of genes correlated with early-stage bladder cancer progression.

Stone R 2nd, Sabichi AL, Gill J, Lee IL, Adegboyega P, Dai MS, Loganantharaj R, Trutschl M, Cvek U, Clifford JL.

Cancer Prev Res (Phila). 2010 Jun;3(6):776-86. doi: 10.1158/1940-6207.CAPR-09-0189. Epub 2010 May 25.

15.

The role of Ras superfamily proteins in bladder cancer progression.

Oxford G, Theodorescu D.

J Urol. 2003 Nov;170(5):1987-93. Review.

PMID:
14532839
16.

Gene expression profile and enrichment pathways in different stages of bladder cancer.

Fang ZQ, Zang WD, Chen R, Ye BW, Wang XW, Yi SH, Chen W, He F, Ye G.

Genet Mol Res. 2013 May 6;12(2):1479-89. doi: 10.4238/2013.May.6.1.

17.

Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.

Simonetti S, Russo R, Ciancia G, Altieri V, De Rosa G, Insabato L.

Int J Surg Pathol. 2009 Jun;17(3):198-205. doi: 10.1177/1066896909333415.

PMID:
19443884
18.

Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder.

Lazzeri M, Vannucchi MG, Spinelli M, Bizzoco E, Beneforti P, Turini D, Faussone-Pellegrini MS.

Eur Urol. 2005 Oct;48(4):691-8.

PMID:
15992990
19.

The expression of urokinase-related genes in superficial and invasive transitional cell carcinoma.

McGarvey TW, Kariko K, Barnathan ES, Thomas J, Malkowicz SB.

Int J Oncol. 1998 Jan;12(1):175-80.

PMID:
9454902
20.

Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.

Juanpere N, Agell L, Lorenzo M, de Muga S, López-Vilaró L, Murillo R, Mojal S, Serrano S, Lorente JA, Lloreta J, Hernández S.

Hum Pathol. 2012 Oct;43(10):1573-82. doi: 10.1016/j.humpath.2011.10.026. Epub 2012 Mar 12.

PMID:
22417847

Supplemental Content

Support Center